Business ❯Pharmaceutical Industry

Drug Market

Obesity Drugs Semaglutide Shortage Weight Loss Drugs Supply Chain Management Regulatory Environment Central Nervous System Treatments FDA Regulations

Pfizer Halts Development of Weight-Loss Pill After Liver Injury in Trial

The pharmaceutical giant discontinues danuglipron following safety concerns but shifts focus to alternative obesity treatments in its pipeline.

Shionogi's COVID Pill Shows Promise in Reducing Transmission

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal